Auger Electron DNA Disruption via Line Emission X-rays
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer treatments, such as radiation therapy and chemotherapy, face challenges in selectively targeting cancer cells while minimizing damage to normal tissues, as they often rely on whole-body delivery of toxic agents, leading to significant side effects and inefficiencies.
Innovation Solution
The method employs line emission x-rays to activate elements that emit Auger electrons, which are coupled with compounds that intercalate or bind to DNA, allowing for localized disruption of cancer cells with minimal impact on healthy tissues by administering these compounds systemically and activating them only with specific x-ray energies in the tumor region.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If whole-body delivery of toxic agents is used in radiation therapy and chemotherapy, then cancer cells can be targeted, but normal tissues are also damaged significantly
Solution Approach 1:
The patent applies local quality by making the therapeutic effect localized rather than systemic. The compound is administered whole-body but remains inactive until exposed to specific x-ray energies at the tumor site. The x-ray activation creates a localized effect zone where only tumor cells receive the high-dose radiation, while normal tissues remain unaffected. This resolves the contradiction by maintaining systemic delivery convenience while achieving localized therapeutic action.
Solution Approach 2:
The patent uses an intermediary mechanism where the compound acts as a mediator between the x-ray activation and the DNA damage effect. The compound contains elements that, when activated by specific x-ray energies, generate Auger electrons that then damage DNA. This intermediary system allows selective activation only at the tumor site where x-rays are applied, preventing systemic toxicity while maintaining therapeutic effectiveness.
2Reliability
If high doses of ionizing radiation are delivered to cancer cells, then tumor treatment effectiveness is improved, but collateral damage to surrounding tissues increases
Solution Approach 1:
The patent achieves local quality by confining the high-dose radiation effect to the immediate vicinity of the activated compound molecules. The Auger electrons have extremely short ranges (a few atomic diameters), creating a highly localized high-dose region around the compound-DNA complex. This allows delivering lethal doses to cancer cell DNA while surrounding tissues receive negligible radiation, resolving the contradiction between treatment effectiveness and collateral damage.
Solution Approach 2:
The patent transitions from a conventional volumetric radiation approach to an atomic-scale localized effect. By using Auger electrons with ranges of only a few atomic diameters, the radiation effect is confined to the nanometer scale around the activated compound. This dimensional change from macroscopic beam irradiation to atomic-scale localized energy deposition enables high tumor cell killing without affecting surrounding tissues.
3Object-affected harmful factors
If selective targeting of cancer cells is attempted, then normal tissue protection is improved, but treatment complexity and difficulty of implementation increase
Solution Approach 1:
The patent applies universality by using a compound that can be administered systemically to the entire body and will activate at any tumor site upon x-ray exposure. The same compound formulation works for different tumor types and locations, and the activation mechanism is universal - any tumor cell containing the compound can be activated by the appropriate x-ray energy. This simplifies the treatment system compared to complex targeted delivery mechanisms while maintaining normal tissue protection.
Solution Approach 2:
The patent employs self-service by allowing the tumor cells themselves to indicate their presence and location. The compound accumulates in tumor cells, and when x-rays are applied, the tumor cells self-activate the therapeutic effect through the Auger electron generation. The system uses the tumor's own characteristics (rapid division, specific metabolism) to facilitate compound accumulation and activation, reducing the need for complex external targeting mechanisms.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables high doses of ionizing radiation to be delivered directly to cancer cells, achieving effective tumor treatment with reduced toxicity to normal tissues, as the Auger electrons cause DNA disruption within a few atomic diameters, minimizing collateral damage.
Implementation Method 1
The method employs line emission x-rays to activate elements that emit Auger electrons
Implementation Method 2
x-rays of an energy selected to cause emission of Auger electrons from said pre-selected element
Implementation Method 3
elements that generate ionizing radiation which will damage cellular DNA
Implementation Method 4
disrupt DNA in the malfunctioning cells
Data Source
AI summary
A method of treating living mammals including humans uses x-rays to disrupt DNA in malfunctioning cells such as cancerous or tumorous cells. A compound comprising a pre-selected element is administered to the mammal so that the compound associates with DNA. Then a localized region of cells which contains the malfunctioning cells is irradiated with line emission x-rays of an energy selected to cause emission of Auger electrons from the pre-selected element of the compound to disrupt DNA proximate to the irradiated pre-selected element. A kit useful for the treatment comprises an x-ray tube capable of emitting monochromatic line emission x-rays and a compound which associates with DNA and has an element which when irradiated emits said Auger electrons.